A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention
Authors:
- Francesco PellicciaFrancesco Pelliccia
- Vincenzo PasceriVPVincenzo Pasceri
- Giuseppe MarazziGMGiuseppe Marazzi
- Giuseppe RosanoGRGiuseppe Rosano
- Cesare GrecoCGCesare Greco
- Carlo GaudioCGCarlo Gaudio
- 1 June 2012
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 163 (6) , 1019-1023
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary InterventionCirculation, 2011
- Safety and Efficacy of Short-Term Celecoxib Before Elective Percutaneous Coronary Intervention for Stable Angina PectorisThe American Journal of Cardiology, 2006
- Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat heartsJournal of Molecular and Cellular Cardiology, 2006
- Antianginal Efficacy of Ranolazine When Added to Treatment With AmlodipineJACC, 2006
- Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary InterventionCirculation, 2005
- Randomized Trial of Atorvastatin for Reduction of Myocardial Damage During Coronary InterventionCirculation, 2004
- Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe anginaJACC, 2004
- Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary interventionJACC, 2003
- Periprocedural myocardial infarction and mortalityJACC, 2003
- Frequency and long-term impact of myonecrosis after coronary stentingEuropean Heart Journal, 2002